Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deutsche Bank AG (DB) vs UnitedHealth Group Inc (UNH) Price & Performance

Deutsche Bank AGTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Deutsche Bank AG vs UnitedHealth Group Inc — how do they compare? Deutsche Bank AG trades at $33.65 (market cap $62.42B), while UnitedHealth Group Inc trades at $374.06 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 5.3× Deutsche Bank AG's market cap, and Deutsche Bank AG pays the higher dividend (3.46%). Which is the better fit depends on your goals — on Pluang, investors hold Deutsche Bank AG for 80 Days and UnitedHealth Group Inc for 97 Days on average.

DBUNH
Market Cap
$62.42B$332.96B
Volume
2,918,7607,273,749
Sector
FinancialsHealth
52-Week High
$41.56$436.35
52-Week Low
$28.37$259.02
Typical Hold Time
80 Days97 Days
Enterprise Value
$77.06B$374.82B
Dividend Yield
3.46%2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deutsche Bank AG

Deutsche Bank (DB) trades at $33.55, down 4.5% on concerns about Q3 investment banking revenue. The stock shows attractive valuation metrics with P/E of 9.09 and P/B of 0.71, while fundamentals improved with 2025 net income reaching $6.93B and profit margin expanding to 21.59%. Technical indicators signal bearish momentum with the price near key support at $33. Recent news highlights the bank's strategic focus on wealth management growth and 2028 return targets.

The outlook remains balanced - strong fundamentals and undervaluation provide upside potential, but near-term headwinds in investment banking and technical weakness suggest cautious optimism. Key risks include execution on strategic targets and market-sensitive revenue streams, while analyst consensus leans neutral with 58% hold ratings.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.

The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DB
100% Buy0% Sell
Avg holding period · 80 Days
UNH
82% Buy18% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Deutsche Bank AG

In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.

Read more on DB →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →